世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000031717

感染症分子診断の日本市場 - 100種のウイルス学、細菌学、寄生虫学、真菌学検査に対する企業の売上とシェア、検査件数、および売上セグメント予測、競合分析、新興技術、最新機器、成長機会

VPGMarketResearch

Japan Infectious Disease Molecular Diagnostics Market: Supplier Sales and Shares, Volume and Sales Segment Forecasts for 100 Virology, Bacteriology, Parasitology and Mycology Tests, Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities

発刊日 2022/03/22

言語英語

体裁PDF/DataPack

ライセンス/価格

0000031717

Local PDF
Global PDF
DataPack

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは国、セクション、市場セグメント、個別の検査別に利用でき、特定の情報ニーズと予算に合わせてカスタマイズできます。

本レポートは、既存企業と潜在的な市場参入企業が、今後5年間の感染症分子診断市場における新たなビジネスチャンスを特定して評価するのに役立つように設計されています。

レポートのハイライト

  • 主要市場のビジネスおよび技術の動向
  • 5年間の検査件数および売上予測
  • 主要な競合他社の市場シェア
  • 主要分析装置の機能比較
  • 革新的製品を開発している主要企業と新興企業の戦略的プロファイル
  • 機器・消耗品サプライヤーにとっての特定の製品・ビジネスチャンス

論理的根拠

感染症分子診断市場は、体外診断産業の中で最も急成長している分野の1つです。今後5年間は、試薬システムと自動化における重要な発展、ならびに革新的なマーケティングアプローチを必要とする幅広い新製品の導入を目の当たりにするでしょう。ただし、ルーチンの臨床検査室への市場浸透率は、増幅方法を備えた費用対効果の高い自動システムの導入に依存します。

感染症分子診断市場によってもたらされる機会をうまく活用するために、多くの企業は、ビジネスおよびマーケティング戦略をサポートして管理される企業の戦略的資産として、新しい分子技術をすでに活用しています。新しいテクノロジー計画をビジネスおよび企業戦略と統合することは、今後5年間で診断会社にとって最も困難な作業の1つになるでしょう。

調査範囲

  • 日本市場の概要
    ➣ 市場セグメント別の感染症のDNAシーケンシングおよび分子診断検査を実施するラボ
    ➣ 5年間の検査件数および売上予測
  • 市場セグメント分析
    ➣ 感染症分子診断試薬キットおよびコンポーネントの主要サプライヤーの売上高よび市場シェア
    ➣ 40以上の感染症分子診断アッセイの5年間の検査件数と売上予測
    ➣ ラボセグメント別のシーケンス市場の包括的な分析
    ➣ 市場力学、動向、構造、規模、成長、主要企業のレビューを含む詳細な市場セグメント分析
  • 製品/技術レビュー
    ➣ 主要な感染症分子診断分析装置の比較
    ➣ 分子診断技術、検査範囲、検出方法、検査自動化の傾向、およびターゲット/シグナル増幅方法の広範なレビュー
    ➣ 新しい分子診断技術や製品を開発している企業、大学、研究センターの世界的なリスト
  • 競合評価
    ➣ 主要企業と新興市場参入者の広範囲にわたる戦略的評価(売上、製品ポートフォリオ、マーケティング戦略、共同作業、R&Dにおける新技術/製品が含まれる)
    ➣ 検査およびアプリケーション別の感染症分子診断製品を開発および販売している企業の包括的なリスト
  • ビジネスチャンスおよび戦略的提案
    ➣ 今後5年間で市場に大きなアピールをもたらす可能性のある特定の新製品開発の機会
    ➣ 新製品の設計基準
    ➣ 代替市場浸透戦略
    ➣ 潜在的な市場参入障壁とリスク
    ➣ 事業計画の問題と懸念

レポート詳細

目次

Table of Contents

I. Introduction

II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels C. Computers, Software and Automation D. Auxiliary Products

III. Design Criteria for Decentralized Testing Products

IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies For Decentralized Testing
Markets

V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VI. Market and Technology Review
A. DNA Sequencing
 1. Introduction
 2. Sequencing Methods
 3. Autoradiography
 4. The Human Genome Project
 5. Sequencing Automation
 6. Image Scanners
 7. Fluorescent Detection
 8. Gene Profiling
 9. Gene Expression
 10. Polymorphism Screening
 11. Protein Interaction Networks
B. DNA and RNA Probe Technologies
 1. Basic Principles
 2. Probe Preparation
 3. The DNA Probe Test
 4. Test Formats
 5. Labeling Techniques
 6. Amplification Methods
C. Detection Technologies
 1. Radioactive Methods a. Overview
  b. Major Isotopes
    O P-32
    O S-35
    O H-3
    O I-125
 2. Non-Isotopic Methods a. Enzymatic Labels
  b. Chemical Labeling
    O Indirect Chemical Labeling
    O Direct Chemical Labeling c. Fluorescence
  d. Chemiluminescence
  e. Electrical Conductivity
D. Molecular Diagnostic Instrumentation Review
 1. Abbott LCx
 2. Beckman Coulter/Biomek FK
 3. BD Viper System with XTR Technology
 4. BD Innova
 5. Becton Dickinson SDA
 6. bioMerieux NucliSENS easyMAG
 7. bioMerieux NucliSENS easyQ and MiniMAG
 8. Bio-Rad GeneScope
 9. Cepheid GeneXpert
 10. Curetis Unyvero
 11. GenMark Dx eSensor XT-8
 12. Hologic/Gen-Probe Panther
 13. Hologic/Gen-Probe Tigris/DTS
 14. HTG Molecular Edge
 15. Life Technologies QuantStudio Dx
 16. Qiagen QIAsymphony RGQ
 17. Roche Cobas Amplicor
 18. Roche Cobas TaqMan 48
 19. Roche Cobas TaqMan
 20. Roche Cobas TaqMan AmpliPrep
 21. Roche LighCycler 480
 22. Roche Cobas 4800
 23. Roche Cobas s 201
 24. Siemens Versant
 25. Tecan LS Series
E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
   - Liquid Transportation and Mixing
   - Separation
   - Reaction
   - Detection
F. Pharmacogenomics
G. Major Applications, Microbiology/Infectious Diseases a. Overview
  b. Major Infectious Diseases
   ° AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
   ° Adenovirus
   ° Aeromonas
   ° Anthrax/Bacillus Anthracis
   ° Arboviruses
   ° Babesiosis
   ° Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
   ° Blastocystis Hominis
   ° Brucella
   ° Campylobacter
   ° Candida
   ° Chagas Disease
   ° Chancroid
   ° Chlamydia
   ° Clostridium Difficile
   ° Coronaviruses
   ° Coxsackieviruses
   ° Creutzfeldt-Jakob’s Disease
   ° Cryptosporidium Parvum
   ° Cyclospora Cayetanensis
   ° Cytomegalovirus
   ° Ebola Virus
   ° E. Coli
   ° EchoVirus
   ° Encephalitis
   ° Enteroviruses
   ° Epstein-Barr Virus
   ° Giardia Lamblia
   ° Gonorrhea
   ° Granuloma Inguinale
   ° Hantavirus
   ° Helicobacter Pylori
   ° Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
   ° Herpes Simplex Virus
   ° Human Herpes Virus-6 (HHV-6)
   ° Influenza Viruses
   ° Legionella
   ° Lyme Disease
   ° Lymphogranuloma Venereum (LGV)
   ° Malaria
   ° Measles (Rubeola)
   ° Meningitis
   ° Microsporidium
   ° Mononucleosis
   ° Mumps
   ° Mycoplasma
   ° Papillomaviruses
   ° Parvovirus B19
   ° Pneumonia
   ° Polyomaviruses
   ° Pseudomonas Aeruginosa
   ° Rabies
   ° Respiratory Syncytial Virus (RSV)
   ° Rhinoviruses
   ° Rotavirus
   ° Rubella
   ° Salmonellosis
   ° Septicemia
   ° Shigellosis
   ° Staphylococcus Aureus
   ° Streptococci
   ° Syphilis
   ° Toxoplasmosis
   ° Trichomonas Vaginalis
   ° Tuberculosis
   ° Vibrio
   ° West Nile Virus
   ° Yersina
H. Competing/complementing
 1. Monoclonal Antibodies/Immunoassays
 2. RNA Probes
 3. Two-Dimensional Electrophoresis
 4. Flow Cytometry

VII. Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

VIII. Competitive Assessments
 - Abbott
 - Affymetrix
 - Agilent Technologies
 - Applied Gene Technologies
 - Arca Biopharma
 - Beckman Coulter/Danaher
 - Becton Dickinson
 - Biokit
 - bioMerieux
 - Bio-Rad
 - Biotest
 - Cepheid
 - Decode Genetics
 - Diadexus
 - Eiken Chemical
 - Elitech Group
 - Enzo Biochem
 - Exact Sciences
 - Fujirebio
 - Grifols
 - Hologic
 - Illumina
 - LabCorp
 - Leica Biosystems
 - Li-Cor Biosciences
 - Myriad Genetics
 - Ortho-Clinical Diagnostics
 - PerkinElmer
 - Proteome Sciences
 - Qiagen
 - Roche
 - Scienion
 - Sequenom
 - Shimadzu
 - Siemens Healthineers
 - Sierra Molecular
 - Takara Bio
 - Tecan Group
 - Thermo Fisher

XIII. Appendix: Major Universities and Research Centers
Developing Molecular Diagnostic Technologies

List of Tables
Major Companies Developing or Marketing AIDS Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Bartonella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Campylobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Candida
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Chlamydia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Clostridium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Coronavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Cryptosporidium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing CMV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Gonorrhea
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hantavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Helicobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hepatitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Herpes
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Influenza
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Legionella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Lyme
Disease Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Measles
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Meningitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mononucleosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mumps
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mycoplasma
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Pneumonia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing RSV
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rotavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rubella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Salmonella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Septicemia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Shigella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Streptococci
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Syphilis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Toxoplasmosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Trichomonas
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Tuberculosis
Molecular Diagnostic and Other Direct
Identification Tests
Japan
Molecular Diagnostics Test Volume And Sales by Major Application 2014-2019
Japan
Laboratories Performing DNA Sequencing by Market Segment 2014
Japan
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment 2014
Japan
Molecular Diagnostics Test Volume by Major Application 2014-2019
Japan
Major Infectious Disease Test Volume by Assay 2014-2019
Japan
Major Infectious Disease Test Volume by Method 2014
Japan
Molecular Diagnostics Market by Major Application 2014-2019
Japan
Molecular Diagnostics Market
Estimated Sales And Market Shares of Major Suppliers 2014
Japan
Major Infectious Disease Diagnostics Market by Assay 2014-2019
Japan
AIDS Testing Market
Estimated Sales by Major Supplier 2014
Japan
Chlamydia Testing Market
Estimated Sales by Major Supplier 2014
Japan
CMV Testing Market
Estimated Sales by Major Supplier 2014
Japan
Gonorrhea Testing Market
Estimated Sales by Major Supplier 2014
Japan
Hepatitis Testing Market
Estimated Sales by Major Supplier 2014
Japan
Hepatitis C Testing Market
Estimated Sales by Major Supplier 2014
Japan
Herpes Testing Market
Estimated Sales by Major Supplier 2014
Japan
Meningitis Testing Market
Estimated Sales by Major Supplier 2014
Japan
Mycoplasma Testing Market
Estimated Sales by Major Supplier 2014
Japan
Pneumonia Testing Market
Estimated Sales by Major Supplier 2014
Japan
Shigella Testing Market
Estimated Sales by Major Supplier 2014

この商品のレポートナンバー

0000031717

TOP